ArticleOncoimmunology

IMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC/Idarubicin activity in preclinical models of non del5q/5q- AML.

Belen Lopez-Millan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.